CSF1R kinase inhibitor and use thereof
AssigneeShanghai Institute of Materia Medica, Chinese Academy of Sciences
InventorsJian Ding, Wenhu Duan, Hua Xie, Meiyu Geng, Caixia Wang, Zhengsheng Zhan, Na Gao, Yang Zhang
Life of this patent
Estimating the term…
Abstract
Provided is the use of a CSF1R kinase inhibitor compound or a pharmaceutically acceptable salt thereof in the preparation of drugs for treating diseases related to the CSF1R kinase signal transduction pathway or drugs for regulating immunization.
Claims2
A method of treating or inhibiting a tumor, comprising administering a therapeutically effective amount of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in combination with an immune checkpoint drug to a subject in need of treatment or inhibition of the tumor, wherein the immune checkpoint drug is an anti-PD-1 antibody or an anti-PD-L1 antibody:
Dependencies are inferred from the claim text.